EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prostate cancer presenting as brain metastasis with concurrent elevation of carcinoembryonic antigen and carbohydrate antigen 19-9 levels: illustrative case

Sosuke Sumiyoshi, Kosuke Fujii, Kazuhiro Kasashima, Masashi Oda iD, Masaaki Saiki iD

Journal of Neurosurgery: Case Lessons · 20.04.2026 · 11 (16)

DOI: 10.3171/case25735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurosurgery: Case Lessons, erschienen am 20.04.2026. Verfasst von Sosuke Sumiyoshi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Otsu Red Cross Hospital, Otsu, Shiga. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Prostate cancer is a common malignancy in men and usually presents with elevated prostate-specific antigen (PSA) levels and metastases to the bones or lymph nodes. Brain metastases are rare, occurring in less than 1% of cases. Concurrent elevation of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) is also uncommon. OBSERVATIONS A 61-year-old man presented with left hemiparesis and cognitive decline. Laboratory tests revealed elevated PSA, CEA, and CA19-9 levels. Imaging revealed a cystic frontal lobe mass, lung nodules, pelvic lymphadenopathy, and a prostatic lesion. MRI confirmed a 5-cm right frontal mass with heterogeneous enhancement and edema. A prostate biopsy revealed adenocarcinoma positive for CEA and CA19-9. Endoscopy revealed no gastrointestinal malignancies. Craniotomy and histopathological examination confirmed the diagnosis of adenocarcinoma. Immunohistochemical analysis revealed CEA positivity, partial CA19-9 positivity, strong NKX3.1 positivity, and PSA negativity. Postoperatively, the patient received androgen deprivation therapy with leuprorelin acetate and darolutamide, along with 5 cycles of docetaxel chemotherapy. At the 24-month follow-up, he remains neurologically stable without recurrence. LESSONS Brain metastases from prostate cancer with elevated CEA and CA19-9 are rare. Although these markers often indicate a poor prognosis, this patient achieved a favorable outcome with multimodal treatment. https://thejns.org/doi/10.3171/CASE25735

Schlagwörter

Stichwörter der Autor:innen

CA19-9CEANKX3.1brain metastasiscarbohydrate antigen 19-9carcinoembryonic antigenprostate cancer

Autor:innen und Institutionen

  • Department of Neurosurgery, Otsu Red Cross Hospital, Otsu, Shiga.
  • Department of Neurosurgery, Shiga General Hospital, Moriyama, Shiga, Japan.

ORCID-Profile: Masashi Oda, Masaaki Saiki

Zitieren

APA

Sumiyoshi, S., Fujii, K., Kasashima, K., Oda, M., & Saiki, M. (2026). Prostate cancer presenting as brain metastasis with concurrent elevation of carcinoembryonic antigen and carbohydrate antigen 19-9 levels: illustrative case. Journal of Neurosurgery: Case Lessons, 11(16). https://doi.org/10.3171/case25735

Vancouver

Sumiyoshi S, Fujii K, Kasashima K, Oda M, Saiki M. Prostate cancer presenting as brain metastasis with concurrent elevation of carcinoembryonic antigen and carbohydrate antigen 19-9 levels: illustrative case. Journal of Neurosurgery: Case Lessons. 2026;11(16). doi:10.3171/case25735

BibTeX
@article{Sumiyoshi2026,
  author = {Sumiyoshi, Sosuke and Fujii, Kosuke and Kasashima, Kazuhiro and Oda, Masashi and Saiki, Masaaki},
  title = {Prostate cancer presenting as brain metastasis with concurrent elevation of carcinoembryonic antigen and carbohydrate antigen 19-9 levels: illustrative case},
  journal = {Journal of Neurosurgery: Case Lessons},
  year = {2026},
  volume = {11},
  number = {16},
  doi = {10.3171/case25735}
}
Kostenlos starten →